Avantor, Inc.
Avantor, Inc. (NYSE: AVTR) is a global provider of products and services for biopharma and healthcare, education and government, and advanced technologies and applied materials customers. It distributes laboratory consumables and equipment through its VWR channel and manufactures proprietary products for life sciences… From the company’s description.
Over the twelve months to Sep 30, 2026, Avantor, Inc. reported revenue of $6.64B, up 0.9% from a year earlier, and net income of $337.20M. Its operating margin was 7.3%, and operations generated $584.70M in cash. In fiscal 2025, it reported revenue of $6.55B, down 3.4% from fiscal 2024, and a net loss of $530.20M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Avantor, Inc. does
In the company’s own words
Avantor, Inc. (NYSE: AVTR) is a global provider of products and services for biopharma and healthcare, education and government, and advanced technologies and applied materials customers. It distributes laboratory consumables and equipment through its VWR channel and manufactures proprietary products for life sciences and medical technology applications. Its offerings include high-purity chemicals and reagents, silicone materials, bioprocessing ingredients, single-use systems, laboratory equipment, and services such as procurement, laboratory operations, and production support. Avantor reports two segments, Laboratory Solutions and Bioscience Production, which serve customers across these markets with materials and consumables, equipment and instrumentation, and services and specialty procurement. Its brands include VWR, J.T. Baker, Masterflex, and NuSil. In 2025, the company served more than 300,000 customer locations in approximately 180 countries and had about 13,500 employees. Its website is www.avantorsciences.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- RADNOR, PA
- Fiscal year end
- December
- CIK
- 1722482
- SIC
- 3826
Financial performance, year by year
Fiscal 2018–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Avantor, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Avantor, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Avantor, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Avantor, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Avantor, Inc.'s last four quarterly filings that the numbers alone won't show?”